Anda belum login :: 20 Feb 2025 09:20 WIB
Detail
ArtikelDesvenlafaxine: An SNRI for Treating Major Depression  
Oleh: Lee, Nelson
Jenis: Article from Bulletin/Magazine - ilmiah internasional
Dalam koleksi: Medical Progress vol. 36 no. 12 (Dec. 2009), page 603.
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: M36.K.2009.02
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelMajor depressive disorder is expected to be the leading cause of global burden of disease by 2020. Antidepressants, together with psychotherapy, remain the main thrust of management of this condition. Desvenlafaxine, an antidepressant, is a new entrant into the class of drugs known as serotonin-norepinephrine reuptake inhibitors, which are used in the treatment of mood disorders, including major depression.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)